Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection.

PubWeight™: 3.72‹?› | Rank: Top 1%

🔗 View Article (PMC 2673564)

Published in AIDS on August 20, 2007


Christopher D Pilcher1, George Joaki, Irving F Hoffman, Francis E A Martinson, Clement Mapanje, Paul W Stewart, Kimberly A Powers, Shannon Galvin, David Chilongozi, Syze Gama, Matthew A Price, Susan A Fiscus, Myron S Cohen

Author Affiliations

1: Center for Infectious Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7030, USA.

Articles citing this

(truncated to the top 100)

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med (2008) 7.46

Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis (2009) 6.96

The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87

Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med (2011) 5.21

Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med (2009) 4.79

Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog (2010) 2.57

Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand. N Engl J Med (2016) 2.34

Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa. HIV Med (2010) 2.27

Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol (2009) 2.18

The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest (2008) 2.12

Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS (2010) 1.89

Transmission networks of drug resistance acquired in primary/early stage HIV infection. AIDS (2008) 1.89

Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidence. J Int AIDS Soc (2010) 1.89

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study. BMJ (2012) 1.71

Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection. AIDS (2010) 1.68

Heterogeneity in host HIV susceptibility as a potential contributor to recent HIV prevalence declines in Africa. AIDS (2009) 1.63

Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort. PLoS One (2010) 1.59

Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis (2011) 1.59

HIV-1 Populations in Semen Arise through Multiple Mechanisms. PLoS Pathog (2010) 1.47

Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis (2013) 1.43

Continued high risk sexual behavior following diagnosis with acute HIV infection in South Africa and Malawi: implications for prevention. AIDS Behav (2011) 1.41

Targeting Trojan Horse leukocytes for HIV prevention. AIDS (2010) 1.40

Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples. J Immunol (2008) 1.36

Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria. AIDS (2010) 1.32

Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol (2013) 1.31

Using HIV networks to inform real time prevention interventions. PLoS One (2014) 1.29

Antiretroviral therapy as HIV prevention: status and prospects. Am J Public Health (2010) 1.25

Cost-effectiveness of provider-based HIV partner notification in urban Malawi. Health Policy Plan (2013) 1.20

Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Med (2011) 1.19

HIV dynamics in seminal plasma during primary HIV infection. AIDS Res Hum Retroviruses (2008) 1.14

Targeted testing for acute HIV infection in North Carolina. AIDS (2009) 1.14

High dead-space syringes and the risk of HIV and HCV infection among injecting drug users. Drug Alcohol Depend (2008) 1.14

Investigating a sexual network of black men who have sex with men: implications for transmission and prevention of HIV infection in the United States. J Acquir Immune Defic Syndr (2012) 1.14

Monitoring HIV vaccine trial participants for primary infection: studies in the SIV/macaque model. AIDS (2009) 1.12

Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions. AIDS (2013) 1.10

AIDS vaccines and preexposure prophylaxis: is synergy possible? AIDS Res Hum Retroviruses (2010) 1.07

Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland. J Clin Microbiol (2014) 1.05

Detection of HIV-1 in alternative specimen types using the APTIMA HIV-1 RNA Qualitative Assay. J Virol Methods (2009) 1.03

Effect of variable transmission rate on the dynamics of HIV in sub-Saharan Africa. BMC Infect Dis (2011) 1.01

Episodic HIV Risk Behavior Can Greatly Amplify HIV Prevalence and the Fraction of Transmissions from Acute HIV Infection. Stat Commun Infect Dis (2012) 1.00

Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009. AIDS (2012) 1.00

The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr (2013) 0.98

T-cell vaccination reduces simian immunodeficiency virus levels in semen. J Virol (2009) 0.98

Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population. PLoS One (2014) 0.98

Modelling the impact of antiretroviral therapy on the epidemic of HIV. Curr HIV Res (2011) 0.98

Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV. J Immunol (2010) 0.97

Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention. AIDS Res Hum Retroviruses (2014) 0.96

Sexual partnership patterns in malawi: implications for HIV/STI transmission. Sex Transm Dis (2011) 0.96

Electricity-free amplification and detection for molecular point-of-care diagnosis of HIV-1. PLoS One (2014) 0.96

Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes. PLoS One (2013) 0.96

Performance of risk-based criteria for targeting acute HIV screening in San Francisco. PLoS One (2011) 0.96

Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus. Dis Model Mech (2013) 0.94

Heterogeneity in Number and Type of Sexual Contacts in a Gay Urban Cohort. Stat Commun Infect Dis (2012) 0.94

Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testing. PLoS One (2013) 0.92

Sexually transmitted infections among patients with acute HIV in North Carolina. Sex Transm Dis (2009) 0.92

Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding. AIDS (2008) 0.91

Genital tract sequestration of SIV following acute infection. PLoS Pathog (2011) 0.90

Biomedical prevention: state of the science. Clin Infect Dis (2014) 0.89

Nonhuman primate models for HIV/AIDS vaccine development. Curr Protoc Immunol (2013) 0.88

Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study. PLoS One (2013) 0.88

HPTN 062: a feasibility and acceptability pilot intervention to reduce HIV transmission risk behaviors among individuals with acute and early HIV infection in Lilongwe, Malawi. AIDS Behav (2014) 0.86

Detectable signals of episodic risk effects on acute HIV transmission: strategies for analyzing transmission systems using genetic data. Epidemics (2012) 0.86

Future of phylogeny in HIV prevention. J Acquir Immune Defic Syndr (2013) 0.85

Contraception and HIV infection in women. Hum Reprod Update (2008) 0.85

Atazanavir: its role in HIV treatment. Expert Rev Anti Infect Ther (2008) 0.85

Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes. Expert Opin Biol Ther (2010) 0.84

Prevalence of undiagnosed acute and chronic HIV in a lower-prevalence urban emergency department. Am J Public Health (2014) 0.83

Antiretrovirals to prevent HIV infection: pre- and postexposure prophylaxis. Curr Infect Dis Rep (2008) 0.83

The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting. J Acquir Immune Defic Syndr (2017) 0.83

Cascade of HIV care and population viral suppression in a high-burden region of Kenya. AIDS (2015) 0.82

Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission. J Antimicrob Chemother (2014) 0.82

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication. EBioMedicine (2017) 0.82

Impact of viral load and the duration of primary infection on HIV transmission: systematic review and meta-analysis. AIDS (2014) 0.82

The HIV treatment cascade in acutely infected people: informing global guidelines. Curr Opin HIV AIDS (2015) 0.81

Impact of early-stage HIV transmission on treatment as prevention. Proc Natl Acad Sci U S A (2014) 0.81

Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study. J Int AIDS Soc (2014) 0.81

HIV-1 vaginal transmission: cell-free or cell-associated virus? Am J Reprod Immunol (2014) 0.81

Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression. J Lab Physicians (2016) 0.81

Partner services in adults with acute and early HIV infection, San Diego, 1996-2014. AIDS (2016) 0.80

Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi. J Acquir Immune Defic Syndr (2016) 0.79

Role of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection. Antimicrob Agents Chemother (2015) 0.79

A generating function approach to HIV transmission with dynamic contact rates. Math Model Nat Phenom (2014) 0.78

Identifying acute HIV infection in Rhode Island. Med Health R I (2009) 0.78

Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies. AIDS (2013) 0.78

Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection. Virol J (2008) 0.78

Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability. AIDS (2016) 0.78

Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. J Int AIDS Soc (2017) 0.77

Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot. J Clin Virol (2013) 0.77

Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model. PLoS One (2015) 0.77

Recent HIV-1 infection: identification of individuals with high viral load setpoint in a voluntary counselling and testing centre in rural Mozambique. PLoS One (2012) 0.77

Modelling the evolution of HIV-1 virulence in response to imperfect therapy and prophylaxis. Evol Appl (2017) 0.76

Chlamydia trachomatis Infection of Endocervical Epithelial Cells Enhances Early HIV Transmission Events. PLoS One (2016) 0.76

Linking immunological and epidemiological dynamics of HIV: the case of super-infection. J Biol Dyn (2013) 0.76

Epigallocatechin gallate inhibits macaque SEVI-mediated enhancement of SIV or SHIV infection. J Acquir Immune Defic Syndr (2017) 0.75

HIV elimination and population viral load. Lancet HIV (2016) 0.75

Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells. PLoS Pathog (2017) 0.75

Diagnosis of acute HIV infection in Connecticut. Conn Med (2009) 0.75

Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A. PLoS One (2015) 0.75

Acute Infections, Cost per Infection and Turnaround Time in Three United States Hospital Laboratories Using Fourth-Generation Antigen-Antibody Human Immunodeficiency Virus Immunoassays. Open Forum Infect Dis (2015) 0.75

Diagnostic technologies in practice: gay men's narratives of acute or recent HIV infection diagnosis. Qual Health Res (2014) 0.75

Articles cited by this

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08

From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect (1999) 17.95

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60

The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol (2004) 7.04

Sexual transmission of HIV. N Engl J Med (1997) 6.84

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet (1997) 6.34

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00

The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 3.75

High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis (1998) 3.46

Modeling plasma virus concentration during primary HIV infection. J Theor Biol (2000) 3.40

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis (1998) 2.98

Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA (2002) 2.94

Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44

Frequent detection of acute primary HIV infection in men in Malawi. AIDS (2004) 2.43

Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS (2000) 2.37

Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest (2004) 2.30

HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS (2001) 2.08

Risk factors and clinical presentation of acute primary HIV infection in India. JAMA (1997) 2.02

Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis (2005) 1.95

A method for fitting regression splines with varying polynomial order in the linear mixed model. Stat Med (2006) 1.05

Pig-tailed macaques infected with human immunodeficiency virus (HIV) type 2GB122 or simian/HIV89.6p express virus in semen during primary infection: new model for genital tract shedding and transmission. J Infect Dis (2001) 0.96

Articles by these authors

Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A (2008) 16.54

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med (2010) 8.51

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60

The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol (2004) 7.04

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med (2009) 7.01

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med (2011) 6.79

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med (2009) 6.22

The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87

Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis (2008) 5.85

Syphilis in China: results of a national surveillance programme. Lancet (2007) 5.76

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS (2009) 5.72

Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA (2004) 5.66

Population-based study of chlamydial infection in China: a hidden epidemic. JAMA (2003) 5.40

Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet (2011) 5.34

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS (2007) 4.89

HIV/AIDS risk among brothel-based female sex workers in China: assessing the terms, content, and knowledge of sex work. Sex Transm Dis (2004) 4.88

AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science (2005) 4.44

HIV prevention transformed: the new prevention research agenda. Lancet (2011) 4.23

Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis (2011) 3.78

High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog (2010) 3.68

Surplus men, sex work, and the spread of HIV in China. AIDS (2005) 3.64

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49

Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet (2005) 3.48

HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS (2011) 3.39

Heterosexually transmitted HIV infection among African Americans in North Carolina. J Acquir Immune Defic Syndr (2006) 3.28

Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis (2006) 3.17

Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. J Infect Dis (2011) 3.16

Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med (2013) 3.10

HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS (2006) 3.05

Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA (2002) 2.94

Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol (2004) 2.91

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (2011) 2.86

Concurrent partnerships among rural African Americans with recently reported heterosexually transmitted HIV infection. J Acquir Immune Defic Syndr (2003) 2.74

Concurrent sexual partnerships among women in the United States. Epidemiology (2002) 2.74

Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. Lancet (2012) 2.69

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. J Infect Dis (2005) 2.54

HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr (2011) 2.49

Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi. AIDS (2008) 2.48

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. J Infect Dis (2010) 2.45

Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44

Frequent detection of acute primary HIV infection in men in Malawi. AIDS (2004) 2.43

The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis (2005) 2.31

Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA (2004) 2.31

Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen. Sex Transm Dis (2006) 2.31

Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet (2013) 2.31

Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest (2004) 2.30

Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci U S A (2012) 2.27

The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis (2011) 2.26

China's syphilis epidemic: a systematic review of seroprevalence studies. Sex Transm Dis (2006) 2.23

Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability. J Clin Microbiol (2003) 2.20

Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health (2006) 2.17

Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis (2010) 2.13

Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med (2009) 2.11

Late postnatal transmission of HIV-1 and associated factors. J Infect Dis (2007) 2.11

High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among MSM. AIDS (2013) 2.10

Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J Clin Microbiol (2008) 2.10

Keep them in school: the importance of education as a protective factor against HIV infection among young South African women. Int J Epidemiol (2008) 2.00

Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial. Pediatr Dermatol (2012) 2.00

Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J Virol (2002) 1.97

Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis (2003) 1.97

A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS (2006) 1.96

Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis (2005) 1.95

The year-long effect of HIV-positive test results on pregnancy intentions, contraceptive use, and pregnancy incidence among Malawian women. J Acquir Immune Defic Syndr (2008) 1.94

Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D. J Acquir Immune Defic Syndr (2006) 1.94

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects. J Infect Dis (2008) 1.91

Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS (2010) 1.89

Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS (2007) 1.89

Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. J Infect Dis (2005) 1.88

HIV incidence among men who have sex with men in China: a meta-analysis of published studies. PLoS One (2011) 1.79

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis (2013) 1.77